Pneumonitis in Patients Receiving Thoracic Radiotherapy and Osimertinib: A Multi-Institutional Study

Introduction: Thoracic radiotherapy (TRT) is increasingly used in patients receiving osimertinib for advanced NSCLC, and the risk of pneumonitis is not established. We investigated the risk of pneumonitis and potential risk factors in this population. Methods: We performed a multi-institutional retr...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Leou Ismael Banla, MD, PhD, Alice Tzeng, MD, PhD, John P. Baillieul, Melin J. Kandekhar, MD, PhD, Kelly J. Fitzgerald, MD, PhD, Jaclyn LoPiccolo, MD, PhD, Holly A. Poitras, Daniel E. Soto, MD, Julia K. Rotow, MD, Lisa Singer, MD, PhD, Henning Willers, MD, David E. Kozono, MD, PhD, Pasi A. Janne, MD, PhD, Raymond H. Mak, MD, Zofia Piotrowska, MD, Florence K. Keane, MD, Benjamin H. Kann, MD
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2023-10-01
Colecção:	JTO Clinical and Research Reports
Assuntos:	Pneumonitis Osimertinib Radiation Lung cancer Tyrosine kinase inhibitors
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S2666364323001029
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!